Xingjiang Bai Hua Cun Pharmaceutical Co. Ltd. (600721)

Overview

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd, originally known as Xinjiang Baihuacun Co., Ltd., underwent a name change in July 2021 to better reflect its evolving focus in the pharmaceutical and biotech industries. Established in 1959, the company has a long history rooted in Urumqi, China. It operates across several sectors including pharmaceutical research and development, clinical trials, biomedicine, and commercial properties, indicating a diverse range of interests and activities within the healthcare and real estate markets. This multidisciplinary approach showcases the company's commitment to innovation and its broad footprint in China's dynamic business landscape.

Products and Services

• Pharmaceutical Research and Development

  Focused on the discovery and development of innovative pharmaceutical products, Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd invests in cutting-edge research to address pressing health issues. This segment involves the initial stages of drug discovery, preclinical studies, and moving successful compounds into clinical trials.

• Clinical Trials

  The company actively engages in clinical trials to test the efficacy and safety of new pharmaceutical compounds. These trials are essential for obtaining regulatory approvals and are a critical step towards bringing new drugs to the market.

• Biomedicine

  With a firm footing in biomedicine, Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd explores the application of biological and physiological principles to clinical practice. This includes the production of biopharmaceuticals, vaccines, and other therapies derived from biological sources.

• Commercial Properties

  Beyond its pharmaceutical ventures, the company also engages in the commercial property market. This includes the ownership, development, and management of properties, further diversifying its business operations and revenue streams.